Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings Authors

Rishi K. Gupta1, Claire J. Calderwood1, Alexei Yavlinsky2, Maria Krutikov1, Matteo Quartagno3, Maximilian C. Aichelburg4, Neus Altet5,6, Roland Diel7,8, Claudia C. Dobler9,10, Jose Dominguez11,12,13, Joseph S. Doyle14,15, Connie Erkens16, Steffen Geis17, Pranabashis Haldar18, Anja M. Hauri19, Thomas Hermansen20, James C. Johnston21, Christoph Lange22,23,24,25, Berit Lange26, Frank van Leth24,27,28, Laura Muñoz29, Christine Roder14,15, Kamila Romanowski21, David Roth21, Martina Sester24,30, Rosa Sloot31, Giovanni Sotgiu24,32, Gerrit Woltmann18, Takashi Yoshiyama33, Jean-Pierre Zellweger24,34, Dominik Zenner1, Robert W. Aldridge2, Andrew Copas1,3, Molebogeng X. Rangaka1,3,35,36, Marc Lipman*37,38, Mahdad Noursadeghi*39, Ibrahim Abubakar*1

[1]  J. Campbell,et al.  Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis , 2020, BMJ.

[2]  Gibril J. Njie,et al.  Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[3]  J. Deeks,et al.  Quantitative Interferon Gamma Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis: A Prospective Cohort Study. , 2019, American journal of respiratory and critical care medicine.

[4]  M. Clements,et al.  Smooth Survival Models, Including Generalized Survival Models [R package rstpm2 version 1.5.1] , 2019 .

[5]  Gerta Rücker,et al.  How to perform a meta-analysis with R: a practical tutorial , 2019, Evidence-Based Mental Health.

[6]  C. Jackson,et al.  Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort. , 2019, The Journal of infectious diseases.

[7]  Paul C. Lambert,et al.  Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study , 2019, Commun. Stat. Simul. Comput..

[8]  Carolin T. Turner,et al.  Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis , 2019, bioRxiv.

[9]  B. Chain,et al.  Blood transcriptomic stratification of short-term risk in contacts of tuberculosis. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Deeks,et al.  Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study , 2019 .

[11]  M. Behr,et al.  Revisiting the timetable of tuberculosis , 2018, British Medical Journal.

[12]  D. Sherman,et al.  Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection , 2018, Clinical Microbiology Reviews.

[13]  S. Self,et al.  Prevention of Infection with Mycobacterium tuberculosis by H4:IC31® Vaccination or BCG Revaccination in Adolescents , 2018, The New England journal of medicine.

[14]  Karel G M Moons,et al.  Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model , 2018, The Lancet Neurology.

[15]  Richard A. White,et al.  Stratification by interferon-γ release assay level predicts risk of incident TB , 2018, Thorax.

[16]  Richard D Riley,et al.  Meta-analysis of prediction model performance across multiple studies: Which scale helps ensure between-study normality for the C-statistic and calibration measures? , 2017, Statistical methods in medical research.

[17]  J. Andrews,et al.  Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study. , 2017, The Lancet. Respiratory medicine.

[18]  C. Haley.  Treatment of Latent Tuberculosis Infection. , 2017, Microbiology spectrum.

[19]  Vincent Audigier,et al.  Multiple Imputation for Multilevel Data with Continuous and Binary Variables , 2017, 1702.00971.

[20]  H. Alsdurf,et al.  The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.

[21]  B. Kampmann,et al.  The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection , 2016, Thorax.

[22]  V. Cook,et al.  Knowledge and Perceptions of Latent Tuberculosis Infection among Chinese Immigrants in a Canadian Urban Centre , 2015, International journal of family medicine.

[23]  Ross J. Harris,et al.  Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries , 2015, European Respiratory Journal.

[24]  R. Chaisson,et al.  Latent Mycobacterium tuberculosis infection. , 2015, The New England journal of medicine.

[25]  A. Orcau,et al.  Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing. , 2015, Annals of the American Thoracic Society.

[26]  Gary S Collins,et al.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC Medicine.

[27]  Yvonne Vergouwe,et al.  Towards better clinical prediction models: seven steps for development and an ABCD for validation. , 2014, European heart journal.

[28]  M. Pai,et al.  Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection , 2014, Clinical Microbiology Reviews.

[29]  A. Hauri,et al.  How can we achieve better prevention of progression to tuberculosis among contacts? , 2013, European Respiratory Journal.

[30]  E. W. Hoskyns,et al.  Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk , 2012, Thorax.

[31]  G. Marks,et al.  Risk of tuberculosis among contacts in a low-incidence setting , 2012, European Respiratory Journal.

[32]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[33]  F. Cobelens,et al.  LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement , 2009, European Respiratory Journal.

[34]  S. Egwaga,et al.  Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  P. Royston,et al.  Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects , 2002, Statistics in medicine.

[36]  Lena Osterhagen,et al.  Multiple Imputation For Nonresponse In Surveys , 2016 .

[37]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[38]  M. Pai,et al.  Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[39]  S. Niemann,et al.  Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update. , 2011, American journal of respiratory and critical care medicine.